Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Antiretroviral drug resistance mutations in the reverse transcriptase gene of HIV-1 isolates from Northern Indian patients: a follow-up study.

Dutta Choudhury S, Chaudhury AK, Kalra R, Andrabi R, Wig N, Biswas A, Bala M, Luthra K.

Arch Virol. 2010 Apr;155(4):563-9. doi: 10.1007/s00705-010-0605-4. Epub 2010 Feb 24.

PMID:
20180140
2.

HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.

Cardoso LP, Pereira GA, Viegas AA, Schmaltz LE, Stefani MM.

J Med Virol. 2010 Mar;82(3):351-7. doi: 10.1002/jmv.21722.

PMID:
20087934
3.

HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.

Cardoso LP, Queiroz BB, Stefani MM.

J Clin Virol. 2009 Oct;46(2):134-9. doi: 10.1016/j.jcv.2009.07.009. Epub 2009 Aug 13.

PMID:
19682948
4.

Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.

Paolucci S, Baldanti F, Campanini G, Zavattoni M, Cattaneo E, Dossena L, Gerna G.

J Med Virol. 2001 Oct;65(2):207-17.

PMID:
11536225
5.

Antiretroviral drug resistance in a respondent-driven sample of HIV-infected men who have sex with men in Brazil.

Bermúdez-Aza EH, Kerr LR, Kendall C, Pinho AA, de Mello MB, Mota RS, Guimarães MD, Alencar CS, de Brito AM, Dourado IC, da Batista SM, Abreu F, de Oliveira LC, de Souza Moraes A, Benzaken AS, Merchan-Hamann E, de Freitas GM, McFarland W, Albuquerque E, Rutherford GW, Sabino E.

J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 3:S186-92. doi: 10.1097/QAI.0b013e31821e9c36.

PMID:
21857316
6.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.

J Med Virol. 2004 Jul;73(3):350-61.

PMID:
15170628
7.

Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.

Kandathil AJ, Kannangai R, Verghese VP, Pulimood SA, Rupali P, Sridharan G, Grant P, Pillay D, Abraham OC.

Indian J Med Microbiol. 2009 Jul-Sep;27(3):231-6. doi: 10.4103/0255-0857.53205.

8.

Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.

Tebit DM, Sangaré L, Tiba F, Saydou Y, Makamtse A, Somlare H, Bado G, Kouldiaty BG, Zabsonre I, Yameogo SL, Sathiandee K, Drabo JY, Kräusslich HG.

J Med Virol. 2009 Oct;81(10):1691-701. doi: 10.1002/jmv.21600.

PMID:
19697403
9.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

10.

Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors.

Saracino A, Monno L, Scudeller L, Cibelli DC, Tartaglia A, Punzi G, Torti C, Lo Caputo S, Mazzotta F, Scotto G, Carosi G, Angarano G.

J Med Virol. 2006 Jan;78(1):9-17.

PMID:
16299731
11.

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.

Babic DZ, Zelnikar M, Seme K, Vandamme AM, Snoeck J, Tomazic J, Vidmar L, Karner P, Poljak M.

Virus Res. 2006 Jun;118(1-2):156-63. Epub 2006 Jan 18.

PMID:
16417938
12.

Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.

Escoto-Delgadillo M, Vázquez-Valls E, Ramírez-Rodríguez M, Corona-Nakamura A, Amaya-Tapia G, Quintero-Pérez N, Panduro-Cerda A, Torres-Mendoza BM.

HIV Med. 2005 Nov;6(6):403-9.

13.

Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.

Bergroth T, Ekici H, Gisslén M, Loes SK, Goh LE, Freedman A, Lampe F, Johnson MA, Sönnerborg A.

J Med Virol. 2009 Jan;81(1):1-8. doi: 10.1002/jmv.21363.

PMID:
19031460
14.

Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.

Bellocchi MC, Forbici F, Palombi L, Gori C, Coelho E, Svicher V, D'Arrigo R, Emberti-Gialloreti L, Ceffa S, Erba F, Marazzi MC, Silberstein FC, Perno CF.

J Med Virol. 2005 Aug;76(4):452-8.

PMID:
15977236
15.

Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.

Derache A, Traore O, Koita V, Sylla A, Tubiana R, Simon A, Canestri A, Carcelain G, Katlama C, Calvez V, Cisse M, Marcelin AG.

Antivir Ther. 2007;12(1):123-9.

PMID:
17503757
16.

Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study.

Mousavi SM, Hamkar R, Gouya MM, Safaie A, Zahraei SM, Yazdani Z, Asbaghi Namini S, Bertagnolio S, Sutherland D, Sandstrom P, Brooks J.

Arch Virol. 2010 Mar;155(3):329-34. doi: 10.1007/s00705-009-0583-6. Epub 2010 Jan 6.

PMID:
20052598
17.

Effects of drug resistance on viral load in patients failing antiretroviral therapy.

Machouf N, Thomas R, Nguyen VK, Trottier B, Boulassel MR, Wainberg MA, Routy JP.

J Med Virol. 2006 May;78(5):608-13.

PMID:
16555280
18.

HIV-1 drug resistance in variants from the female genital tract and plasma.

Kemal KS, Burger H, Mayers D, Anastos K, Foley B, Kitchen C, Huggins P, Schroeder T, Picchio G, Back S, Gao W, Meyer WA 3rd, Weiser B.

J Infect Dis. 2007 Feb 15;195(4):535-45. Epub 2007 Jan 8.

19.

Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.

Ríos M, Delgado E, Pérez-Alvarez L, Fernández J, Gálvez P, de Parga EV, Yung V, Thomson MM, Nájera R.

J Med Virol. 2007 Jun;79(6):647-56.

PMID:
17457921
20.
Items per page

Supplemental Content

Write to the Help Desk